Enveric Biosciences enters definitive agreement for an all-stock transaction to acquire MagicMed Industries
Once closing is complete, Magic Med CEO Dr Joseph Tucker will be appointed chief executive officer of the enlarged company and David Johnson, chairman and CEO of Enveric will be appointed executive chairman